OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The genetic structure of SARS‐CoV‐2 does not rule out a laboratory origin
Rossana Segreto, Yuri Deigin
BioEssays (2020) Vol. 43, Iss. 3
Open Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

Tracing the origins of SARS-COV-2 in coronavirus phylogenies: a review
Erwan Sallard, José Halloy, Didier Casañe, et al.
Environmental Chemistry Letters (2021) Vol. 19, Iss. 2, pp. 769-785
Open Access | Times Cited: 65

The Emergence of the Spike Furin Cleavage Site in SARS-CoV-2
Yujia A. Chan, Shing H. Zhan
Molecular Biology and Evolution (2021) Vol. 39, Iss. 1
Open Access | Times Cited: 60

The origins of COVID‐19 pandemic: A brief overview
Ying‐Jian Hao, Yulan Wang, Mei‐Yue Wang, et al.
Transboundary and Emerging Diseases (2022) Vol. 69, Iss. 6, pp. 3181-3197
Open Access | Times Cited: 42

Meta-analysis to explain unknown causes of the origins of SARS-COV-2
Mario Coccia
Environmental Research (2022) Vol. 211, pp. 113062-113062
Open Access | Times Cited: 39

Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19
Rohan Ameratunga, Hilary Longhurst, Richard Steele, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 10, pp. 3575-3583
Open Access | Times Cited: 48

What we know and what we need to know about the origin of SARS-CoV-2
José L. Domingo
Environmental Research (2021) Vol. 200, pp. 111785-111785
Open Access | Times Cited: 48

Changing Dynamics with COVID-19: Future Outlook
Cengiz Kahraman, Christian Orobello, Giuseppe T. Cirella
Advances in 21st century human settlements (2021), pp. 235-252
Closed Access | Times Cited: 38

Should we discount the laboratory origin of COVID-19?
Rossana Segreto, Yuri Deigin, Kevin McCairn, et al.
Environmental Chemistry Letters (2021) Vol. 19, Iss. 4, pp. 2743-2757
Open Access | Times Cited: 36

An updated review of the scientific literature on the origin of SARS-CoV-2
José L. Domingo
Environmental Research (2022) Vol. 215, pp. 114131-114131
Open Access | Times Cited: 25

An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2
Jacques van Helden, Colin D. Butler, Guillaume Achaz, et al.
The Lancet (2021) Vol. 398, Iss. 10309, pp. 1402-1404
Open Access | Times Cited: 26

On the origin of SARS-CoV-2—The blind watchmaker argument
Chung‐I Wu, Haijun Wen, Jian Lü, et al.
Science China Life Sciences (2021) Vol. 64, Iss. 9, pp. 1560-1563
Open Access | Times Cited: 24

New branch and definitions against emerging infectious diseases
Bruce Masonova SOLOZAY BEMENA, André Totohasina, Daniel Rajaonasy Feno, et al.
Academia Medicine (2025) Vol. 2, Iss. 1
Open Access

Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges
Fares E.M. Ali, Zuhair M. Mohammedsaleh, Mahmoud Ali, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 15, pp. 1531-1552
Open Access | Times Cited: 23

There is no “origin” to SARS-CoV-2
Roger Frutos, Olivier Pliez, Laurent Gavotte, et al.
Environmental Research (2021) Vol. 207, pp. 112173-112173
Open Access | Times Cited: 21

Origin of COVID-19: Dismissing the Mojiang mine theory and the laboratory accident narrative
Roger Frutos, Émilie Javelle, Celine Barberot, et al.
Environmental Research (2021) Vol. 204, pp. 112141-112141
Open Access | Times Cited: 21

The (apparent) antibody paradox in COVID-19
Rohan Ameratunga, See‐Tarn Woon, Edward Lea, et al.
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 4, pp. 335-345
Open Access | Times Cited: 15

Sequelae and Comorbidities of COVID-19 Manifestations on the Cardiac and the Vascular Systems
Yashvardhan Batta, Cody King, John B. Johnson, et al.
Frontiers in Physiology (2022) Vol. 12
Open Access | Times Cited: 13

Severe COVID-19 is a T cell immune dysregulatory disorder triggered by SARS-CoV-2
Rohan Ameratunga, See‐Tarn Woon, Richard Steele, et al.
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 6, pp. 557-565
Closed Access | Times Cited: 13

SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?
Rohan Ameratunga, Euphemia Leung, See‐Tarn Woon, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 9, pp. 2267-2273
Open Access | Times Cited: 13

Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19)
Ting Wu, Shuntong Kang, Wenyao Peng, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 17

Genomic Bootstrap Barcodes and Their Application to Study the Evolution of Sarbecoviruses
Alexandre Hassanin, Opale Rambaud, Dylan Klein
Viruses (2022) Vol. 14, Iss. 2, pp. 440-440
Open Access | Times Cited: 12

Page 1 - Next Page

Scroll to top